MedPath

Evaluation of One-day Polyethylene Glycol Powder Solution for Colonoscopy in Children

Completed
Conditions
Water-Electrolyte Imbalance
Interventions
Registration Number
NCT01626040
Lead Sponsor
Children's Hospital of Philadelphia
Brief Summary

The purpose of this study is to examine the effects of current standard of care Polyethylene Gylcol powder (PEG-P)colonoscopy preparation on a patient's serum electrolytes, tolerance of the prep, and how well the bowel is cleansed. The primary aim is to determine the proportion of patients with clinically significant serum electrolyte abnormalities at the time of colonoscopy and how well the prep is tolerated. Secondary objectives include: 1) how well the bowel is cleansed with this preparation, and 2) to determine the most effective way to communicate instructions about the bowel preparation with the child and family.

Detailed Description

Design is prospective, descriptive observational study involving a single clinical encounter in the Endoscopy suite at CHOP Main at the time of colonoscopy. Patients prescribed the standard of care dosage for PEG-P by their primary gastroenterologist are considered for this study. Study procedures include collection of data from patients that are prescribed the PEG-P dose. In order to evaluate the safety, tolerability, and adherence to PEG-P bowel preparation, data collections include the following: review of medical records, tracking of communication from subjects/parents, blood draw, questionnaire and quality of prep will be assessed. Questionnaire results will be obtained at the initial and only visit. Patients will be given a questionnaire prior to colonoscopy to rate symptoms, ease of preparation and to rate the effectiveness of communication about the preparation. On the day of colonoscopy, prior to the procedure, patients will have an IV placed per standard procedure. At the time of IV placement, a basic metabolic panel and serum magnesium and phosphorus levels will be drawn through the IV for assessment of electrolyte abnormalities. Serum glucose will be captured from medical records as this is collected with standard of care. Patient/parents will grade the preparation tolerance filling out a questionnaire prior to colonoscopy. During colonoscopy, the endoscopist will grade the quality of preparation on a validated residual stool survey (Aronchick scale).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
178
Inclusion Criteria
  • Subjects age 1 - 18 years
  • patients receiving standard of care dosing for polyethylene glycol powder
  • patients who had electrolyte results within the last 60 days of enrollment
  • parental / guardian permission (informed consent)
Exclusion Criteria
  • Patients on the GI inpatient or consult service
  • Weight less than 10 kg
  • Pregnant or lactating females
  • Non-English speaking patient or parent
    1. Parents/guardians or subjects who, in the opinion of the Investigator/Study team, may be non-compliant with study schedules or procedures

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
PEG-P preppolyethylene glycol powderChildren taking the one day polyethylene glycol powder preparation for outpatient colonoscopy
Primary Outcome Measures
NameTimeMethod
electrolyte disturbancesat the time of colonoscopy

the proportion of patients with clinically significant serum electrolyte abnormalities at the time of colonoscopy

PEG-P preparation toleranceat the time of colonoscopy

Responses to a questionnaire regarding the tolerance of the PEG-P prep will be recorded

Secondary Outcome Measures
NameTimeMethod
Colonoscopy preparation efficacyat the time of colonoscopy

To assess the proportion of patients that have excellent or good quality preparation as scored by a validated residual stool survey called the Aronchick scale

Effective communicationat the time of colonoscopy

Effectiveness of communication strategy about the prep and availability of staff to address questions reported by parents will be summarized

Trial Locations

Locations (1)

Children's Hospital of Philadelphia

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath